Participants 25 53 4
patients with anemia and CKD
Participants 118 161 4
patients with chronic kidney disease (CKD).
Participants 593 631 3
patients with CKD stages 1 to 5 and 5D
Participants 818 860 6
750 patients with CKD stages 1 to 5 and 5D
Participants 1111 1184 6
750 randomly assigned patients with CKD, 60% were not on dialysis therapy
Participants 1186 1245 6
713 patients received ferumoxytol, and 711 received placebo
Participants 2083 2128 4
anemic patients with CKD stages 1 to 5 and 5D
